Live Breaking News & Updates on Cannabics Pharmaceutical

Stay updated with breaking news from Cannabics pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine

Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Facebook Cannabicspharmaceuticals , Instagram Cannabics , Ilya Reznik , Dana Ben , Eyal Barad , Canadian Consortium For The Investigation Of Cannabinoids , Company On Twitter Cannabics , International Cannabinoid Research Society , Ministry Of Health , Consulting Center , Israeli Parliament Knesset Committee For Drugs , Partnership Networking , Psilocin Research Program , International Speaker On Cannabinoid Medicine , Exchange Commission , Cannabics Pharmaceuticals , Prnewswire Cannabics Pharmaceuticals Inc , Israeli Ministry Of Health , International Association For Cannabinoid Medicines , Cannabics Pharmaceuticals Inc , Psychedelic Inspired , Israeli Ministry , Cannabics Pharmaceutical , Psychedelic Inspired Medicine , Adult Forensic , Clinical Neuropsychiatry ,

The European Patent Office Grants Cannabics Pharmaceuticals Patent for Company's Personalized Medicine Drug Discovery Technology

The European Patent Office Grants Cannabics Pharmaceuticals Patent for Company s Personalized Medicine Drug Discovery Technology
USA - English
Share this article
Share this article
TEL AVIV, Israel and BETHESDA, Md., May 25, 2021 /PRNewswire/ Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that the company s patent titled:
System and Method for High Throughput Screening of Cancer Cells has been granted by the
European Patent Office.
Outside the European territory, corresponding patents under the same title have already been granted in Israel and in South Africa. Further to that, corresponding patents with said title are also currently under examination in numerous other territories including the US and Canada, as well as in Mexico where earlier this month the company received Notice of Allowance from the Mexican Patent and Trademark Office (IMPI). ....

South Africa , Eyal Ballan , Gabriel Yariv , Facebook Cannabicspharmaceuticals , Instagram Cannabics , European Patent Office , Company On Twitter Cannabics , Ministry Of Health , Exchange Commission , Trademark Office , Cannabics Pharmaceuticals , Prnewswire Cannabics Pharmaceuticals Inc , Cannabics Pharmaceuticals Inc , High Throughput Screening , European Patent , Mexican Patent , Cannabics Pharmaceutical President , Cannabics Pharmaceutical , Private Securities Litigation Reform Act , கண் பள்ளன் , ஐரோப்பிய காப்புரிமை அலுவலகம் , அமைச்சகம் ஆஃப் ஆரோக்கியம் , பரிமாற்றம் தரகு , முத்திரை அலுவலகம் , ஐரோப்பிய காப்புரிமை , மெக்ஸிகன் காப்புரிமை ,

Cannabics Pharmaceuticals Receives Patent "Notice of Allowance" From The Mexican Patent and Trademark Office (IMPI)

Cannabics Pharmaceuticals Receives Patent Notice of Allowance From The Mexican Patent and Trademark Office (IMPI)
USA - English
Share this article
Share this article
TEL AVIV, Israel and BETHESDA, Md., May 6, 2021 /PRNewswire/ Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that it had received Notice of Allowance from the
Mexican Patent and Trademark Office (IMPI) in relation to the company s patent titled: System and method for high throughput screening of cancer cells . The decision of the Mexican patent authority follows the European Patent Office (EPO)
Intention to Grant a European Patent notice to the company from October 2020, concerning the same patent application. ....

South Africa , Facebook Cannabicspharmaceuticals , Instagram Cannabics , Eyal Barad , Company On Twitter Cannabics , European Patent Office , Ministry Of Health , Trademark Office , Exchange Commission , Cannabics Pharmaceuticals , Prnewswire Cannabics Pharmaceuticals Inc , Cannabics Pharmaceuticals Inc , Mexican Patent , Cannabics Pharmaceutical , Private Securities Litigation Reform Act , கண் பராட் , ஐரோப்பிய காப்புரிமை அலுவலகம் , அமைச்சகம் ஆஃப் ஆரோக்கியம் , முத்திரை அலுவலகம் , பரிமாற்றம் தரகு , மெக்ஸிகன் காப்புரிமை , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,

Cannabics Pharmaceuticals Initiates In-Vivo Animal Studies for FDA Pre-IND Meeting Package

Share this article
Share this article
TEL AVIV, Israel and BETHESDA, Maryland, Dec. 21, 2020 /PRNewswire/ Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based therapeutic formulations and medicines, announced today that it has initiated a series of proof of concept (POC),
in-vivo, animal model studies to test its drug candidate RCC-33 on mice transplanted with colorectal cancer tumor cell lines. Study results are to be included in the data package being prepared for submission to the US Food and Drug Administration along with a request for a pre-IND Meeting.
The animal studies follow previous successful completion of ....

Eteläuomen Läi , United States , Eyal Ballan , Gabriel Yariv , Facebook Cannabicspharmaceuticals , Instagram Cannabics , Company On Twitter Cannabics , Ministry Of Health , Drug Administration , Exchange Commission , Cannabics Pharmaceuticals , Prnewswire Cannabics Pharmaceuticals Inc , Cannabics Pharmaceuticals Inc , Drug Candidate , Helsinki Approved Protocol , Cannabics Pharmaceutical President , Cannabics Pharmaceutical , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , கண் பள்ளன் , அமைச்சகம் ஆஃப் ஆரோக்கியம் , பரிமாற்றம் தரகு , மருந்து வேட்பாளர் , ஹெல்சின்கி அங்கீகரிக்கப்பட்டது ப்ரோடொகால் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,